Michaela Reiser

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Judith Haschka, Matthias Englbrecht, Axel J. Hueber et al. · Annals of the Rheumatic Diseases · 2015 · 202 citations

Medicine, Pharmacotherapy, Disease Prevention +15

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Jürgen Rech, Axel J. Hueber, Stephanie Finzel et al. · Annals of the Rheumatic Diseases · 2015 · 95 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Camille P. Figueiredo, Holger Bang, Jayme Fogagnolo Cobra et al. · Annals of the Rheumatic Diseases · 2016 · 63 citations

Life Sciences, Immunology, Internal Medicine +17

Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs

Asmir Vodenčarević, Koray Taşçılar, F Hartmann et al. · Arthritis Research & Therapy · 2021 · 60 citations · Full text

Computing, Pharmacology, Pharmacotherapy +17

Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial

Koray Taşçılar, Melanie Hagen, Arnd Kleyer et al. · The Lancet Rheumatology · 2021 · 31 citations

Medicine, Pharmacotherapy, Rheumatology +11